HIF1A and pulmonary hypertension: Selective ET-1-A antagonist can inhibit hypoxic pulmonary vessel contraction, inhibit or decrease pulmonary hypertension under hypoxia [16], through which hypoxia can regulate ET-1 gene expression via inducing HIF-1α and ET-1 levels were linearly correlated with pulmonary artery pressure.